Sign in

Joan Mancuso

@joanmancusombc.bsky.social
217 followers 210 following 101 posts

#PatientAdvocate living with #metastaticbreastcancer since 2007 (treatment pause since 2020). Always supporting the patient voice. Presenter, panelist and author for #breastcancer.

PostsRepliesMedia
Reposted by Joan Mancuso
Triage Cancer @triagecancer.org · 23/09/2026
Medicare Open Enrollment is right around the corner! Sign up for our free webinar on October 13 to learn strategies for comparing plans, practical tips for choosing coverage, and what’s changing with Medicare in 2027. #CanSky Register today: TriageCancer.org/Webinars
043
Reposted by Joan Mancuso
Dr. Tom Frieden @drtomfrieden.bsky.social · 25/09/2026
Their success shows that it’s possible to count every death within days, find the cause of most, and use that data to make public health decisions. Other countries can follow their lead. substack.com/@tomfrieden/...
substack.com
To Make Every Life Count, Count Every Life
What Rwanda can teach the world about measuring health
061
Reposted by Joan Mancuso
Dr. Tom Frieden @drtomfrieden.bsky.social · 25/09/2026
Public health starts with two questions: what’s killing people, and what can stop these killers? Rwanda created a system to answer these questions.
163
Reposted by Joan Mancuso
Stanford Medicine @stanfordmedicine.bsky.social · 25/09/2026
Estrogen-only menopausal hormone therapy may reduce the risk of Alzheimer’s disease in women, according to a new study by Stanford Medicine investigators. stan.md/4g327iE
stan.md
Study ties estrogen-based menopausal hormone therapy to lower Alzheimer’s risk
Some studies have reported that menopausal hormone therapy raises dementia risk. A new study that analyzed Alzheimer’s-disease hallmarks in autopsied brains indicates the opposite.
011
Reposted by Joan Mancuso
Cancer Vaccine Institute (CVI) at UW Medicine @uwcvi.bsky.social · 21/09/2026
Dr. Nora Disis, CVI Director, is a lead author of a new review article published by @jama.com. The review explores the science behind cancer vaccines and the field’s shifting focus toward preventive approaches. Read more: www.uwcvi.org/post/dr-disi... #CancerVaccines #CancerResearch
022
Reposted by Joan Mancuso
Rita Rubin @ritarubin.bsky.social · 18/09/2026
My caffeinated beverage of choice is iced tea, thanks to my time working in Dallas. If yours is energy drinks, you might want to reconsider your choice, according to the American Heart Association. My latest for @jama.com:
032
Reposted by Joan Mancuso
Siteman Cancer Center @sitemancenter.bsky.social · 26/09/2026
See all presentations: siteman.washu.edu/washu-medicine-radiation-oncologists-at-siteman-cancer-center-to-showcase-findings-at-astro26/
011
Reposted by Joan Mancuso
Siteman Cancer Center @sitemancenter.bsky.social · 26/09/2026
#ASTRO26 draws 10,000+ healthcare professionals from around the world. @washumedicine.bsky.social radiation oncologists at Siteman Cancer Center will be among the most prominent voices in the room.
siteman.washu.edu
WashU Medicine Radiation Oncologists at Siteman Cancer Center to Showcase Findings at ASTRO 2026
From Phase III prostate cancer trials to first-in-human adaptive radiotherapy, Siteman Cancer Center will highlight major advances at the 68th ASTRO Annual…
111
Reposted by Joan Mancuso
Dana-Farber Cancer Institute @danafarber.bsky.social · 26/09/2026
Dana-Farber researchers in collaboration with 23andMe identified a rare genetic risk factor for lung cancer in people who have never smoked. The findings could help shape future screening strategies for people who carry the EGFR mutation. Read more in the @nytimes.com.
bit.ly
This Rare Gene Drastically Raises Lung Cancer Risk in People Who Never Smoked
The gene is found predominantly in Southern Appalachia and may be one of the most powerful cancer-risk mutations ever found.
041
Reposted by Joan Mancuso
American College of Cardiology @accintouch.bsky.social · 27/09/2026
#AFibAwarenessMonth: Explore #CardioSmart’s #AFib Resource Hub for patient-friendly resources on symptoms, treatment options, medications and self-management strategies. Share these resources to help patients make informed care decisions ➡️ bit.ly/4x4rQNY #CardioSky
042
Reposted by Joan Mancuso
American College of Cardiology @accintouch.bsky.social · 27/09/2026
#AFibAwarenessMonth: Explore #CardioSmart’s #AFib Resource Hub for patient-friendly resources on symptoms, treatment options, medications and self-management strategies. Share these resources to help patients make informed care decisions ➡️ bit.ly/4x4rQNY #CardioSky
043
Reposted by Joan Mancuso
UT MD Anderson Cancer Center @mdanderson.bsky.social · 27/09/2026
At #ASTRO26, UT MD Anderson faculty will present nearly 70 abstracts that showcase the latest research focused on improving outcomes and quality of life for cancer patients undergoing radiation therapy. Learn more: spr.ly/6049BGlqoR #EndCancer
spr.ly
UT MD Anderson at ASTRO
At the American Society for Radiation Oncology (ASTRO) Annual Meeting, UT MD Anderson experts showcase their pacesetting research and join colleagues for discussion on the latest advances in radiation oncology.
022
Reposted by Joan Mancuso
NEJM.org @nejm.org · 27/09/2026
In patients with #AFib and intermediate stroke risk, direct oral anticoagulation led to a lower risk of stroke, systemic embolism, major bleeding, or death from cardiovascular causes than no anticoagulation. Full SINGLE-AF trial results and Research Summary: nej.md/4ii61XB #ESCCongress
This image contains an excerpt from the Research Summary "Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk" published in the New England Journal of Medicine. It includes a visual representation of a patient with atrial fibrillation and an intermediate risk of stroke. Patient demographics are detailed as 1803 adults, average age of 60 years. The bottom half contains illustrations of the two treatment options: direct oral anticoagulant (DOAC) therapy or no anticoagulation. A prompt to read the full Research Summary at NEJM.org sits at the bottom.
053
Reposted by Joan Mancuso
ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 27/09/2026
🔊Join the growing global ASCO PallOnc COP as we kick off the year nurturing old and new connections while gearing up for another successful year. DM for the zoom meeting link and to join our listserv. 🕒We can't wait to greet you all on Sep 29, 2026 @ 16:00 EST.
143
Reposted by Joan Mancuso
Darcy Burbage, DNP, RN, AOCN @darcyburbage.bsky.social · 09/09/2026
Exciting day for cancer care in Delaware! Senate Bill 120 expanding insurance coverage for #BiomarkerTesting was signed into law! TY to the legislators, advocacy organizations & most importantly patient advocates for sharing their stories 🧬🩺❤️!
123
Reposted by Joan Mancuso
ECOG-ACRIN Cancer Research Group @eaonc.bsky.social · 02/09/2026
Federal investment in #cancer #ClinicalTrials matters. A recent study found that federally funded trials are more likely to examine rare & pediatric cancers, prevention strategies, supportive care, & ways to reduce treatment burden. More via @theaacr.bsky.social's blog: bit.ly/4zS7fzm
bit.ly
Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More
The August 2026 edition of “Unboxing Cancer News” highlights a transmissible cancer, federal- vs. industry-funded clinical trials, and more.
011
Reposted by Joan Mancuso
Darcy Burbage, DNP, RN, AOCN @darcyburbage.bsky.social · 02/09/2026
Happy #CNSWeek2026!
052
Reposted by Joan Mancuso
JAMA @jama.com · 29/08/2026
🩺 In Japan, elective #AtrialFibrillation ablation was associated with low in-hospital mortality during a decade of rapid expansion, with no evidence that broader adoption reduced procedural safety. #ESCCongress ja.ma/4qEw6SO
Line graph: In-hospital mortality after elective atrial fibrillation ablation, 2012-2022. Y-axis: Mortality %. Annual mortality (orange line) peaked in 2013 (~0.07%), then generally declined. The 3-year moving average (blue line) shows an overall decreasing trend from 2014 to 2022 (P=.04).
083
Reposted by Joan Mancuso
Fred Hutch @fredhutch.org · 28/08/2026
Fred Hutch Cancer Center’s Lynn Symonds, MD, who researches and treats #breastcancer, received a prestigious American Society of Clinical Oncology Career Development Award for work on a new biomarker for triple-negative breast cancer. Read more: bit.ly/3UZAGzd
011
Reposted by Joan Mancuso
Open Box Science @openboxscience.bsky.social · 26/08/2026
OBS Neuroimmunology Webinar — August 27 Somatic mutations reveal the ontogeny of microglia in human aging (Nature 2026) *Speaker: Julia Belk (Stanford University) @juliabelk.bsky.social @stanfordmedicine.bsky.social Moderator: @asalboix.bsky.social *Zoom link: us02web.zoom.us/meeting/regi...
041
Reposted by Joan Mancuso
American Society of Clinical Oncology @ascocancer.bsky.social · 26/08/2026
Updated Guideline: Breast Cancer Follow-Up & Surveillance New recommendations feature a risk-based approach to care, offering virtual or in-person visits, routine mammography, & tailored surveillance for high-risk patients. Read the updated guideline: bit.ly/4gqKJ7C
033
Reposted by Joan Mancuso
Nature @nature.com · 20/08/2026
The US National Science Foundation will award about 30% fewer new research grants this fiscal year than in the last one, Nature has learnt. go.nature.com/3UcGoNW
go.nature.com
Exclusive: NSF set to issue lowest number of new grants in four decades
The US science-funding agency is withholding $1 billion of its budget so that the money can go to a special White House project.
4137106
Reposted by Joan Mancuso
Nature Cancer @natcancer.nature.com · 21/08/2026
Our August issue is live!🏖️ Featuring copper dependency in AML, iron-mediated ferroptosis, GPNMB-directed CAR-T cell therapy, IDH1-mutant vaccine in phase 1 trial, and more 🔗 nature.com/natcancer/vo...
031
Reposted by Joan Mancuso
biologist077.bsky.social @biologist077.bsky.social · 22/08/2026
personalized mrna cancer vaccines just hit phase 3 success for melanoma in 1,137 patients. combined with keytruda, it significantly reduced recurrence. this is the first late-stage win for individualized mrna therapy.
gavi.org
Personalized mRNA Cancer Vaccine Shows Success in Phase 3 Melanoma Trial
A personalized mRNA cancer vaccine, developed by Moderna and Merck, significantly reduced the risk of recurrence and spread of high-risk melanoma in a large-scale Phase 3 clinical trial. This breakthr
12411
Reposted by Joan Mancuso
Open Box Science @openboxscience.bsky.social · 22/08/2026
OBS Neuroimmunology Webinar — August 27 Somatic mutations reveal the ontogeny of microglia in human aging (Nature 2026) *Speaker: Julia Belk (Stanford University) @juliabelk.bsky.social @stanfordmedicine.bsky.social *Zoom link: us02web.zoom.us/meeting/regi...
052
Reposted by Joan Mancuso
Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 24/08/2026
In this short #BreastCancerBreakthroughs #ASCO2026 Highlight, Harold Burstein, MD, PhD, and Adrienne Waks, MD discuss the #HER2Climb-05 trial and how it impacts treatment for HER2+ #MetastaticBreastCancer. youtu.be/1DNsWW9s1t0?...
youtu.be
2026 ASCO Breast Cancer Highlights: HER2CLIMB-05 | Dana-Farber Cancer Institute
YouTube video by Dana-Farber Cancer Institute
011
Reposted by Joan Mancuso
OncLive @onclive.bsky.social · 24/08/2026
The European Commission approved sacituzumab govitecan plus pembrolizumab for treatment-naive, PD-L1-positive metastatic triple-negative breast cancer. #bcsm #oncology www.onclive.com/view/europea...
onclive.com
European Commission Approves Sacituzumab Govitecan Plus Pembrolizumab for Frontline PD-L1+ mTNBC | OncLive
The European Commission approved sacituzumab govitecan plus pembrolizumab for treatment-naive, PD-L1-positive metastatic triple-negative breast cancer.
021
Reposted by Joan Mancuso
OncLive @onclive.bsky.social · 24/08/2026
The oral pan-RAS molecular glue ERAS-0015 has received @fda.gov fast track designation for the management of metastatic pancreatic adenocarcinoma. #pancsm #oncology www.onclive.com/view/fda-gra...
onclive.com
FDA Grants Fast Track Designation to Pan-RAS Molecular Glue ERAS-0015 for Metastatic Pancreatic Adenocarcinoma | OncLive
The oral pan-RAS molecular glue ERAS-0015 has received FDA fast track designation for the management of metastatic pancreatic adenocarcinoma.
011
Reposted by Joan Mancuso
The Francis Crick Institute @crick.ac.uk · 24/08/2026
Join us for our first online AI for Biological Discovery Seminar, where our Chief AI Scientist Mihaela van der Schaar will host Caroline Uhler to discuss her research at the intersection of machine learning, statistics and genomics. Learn more and book your free ticket: bit.ly/4xAvNLL
bit.ly
AI in Biology Seminar | Professor Caroline Uhler
A new AI for Biological Discovery Seminar Series, presented by the Francis Crick Institute.
0118
Reposted by Joan Mancuso
Open Box Science @openboxscience.bsky.social · 24/08/2026
OBS Neuroimmunology Webinar — August 27 Somatic mutations reveal the ontogeny of microglia in human aging (Nature 2026) *Speaker: Julia Belk (Stanford University) @juliabelk.bsky.social @stanfordmedicine.bsky.social *Zoom link: us02web.zoom.us/meeting/regi...
031
Reposted by Joan Mancuso
OncLive @onclive.bsky.social · 15/08/2026
WATCH: Alessandro A. Viansone, MD, highlights potential future updates to the HER2-positive breast cancer treatment paradigm. @gustaveroussy.fr #bcsm #oncology Watch more insights from Dr Viansone on our site: www.onclive.com/view/dr-vian...
011
Reposted by Joan Mancuso
Jame Abraham, MD, FACP @jameabraham.bsky.social · 15/08/2026
Undocumented migration does not raise crime rates, huge study finds www.nature.com/articles/d41...
nature.com
Undocumented migration does not raise crime rates, huge study finds
Analysis of neighbourhoods in more than 100 US cities finds no evidence that rising numbers of undocumented immigrants are linked with violent crime.
022
Reposted by Joan Mancuso
Fred Hutch @fredhutch.org · 16/08/2026
Let cancer eat cake. 🍰 A Fred Hutch study led by @lucasbsullivan.bsky.social finds that feeding NRF2-mutated tumors too much of a nutrient they crave makes them vulnerable to slower growth and cell death. bit.ly/45Yx9Ua
bit.ly
Let cancer eat cake
Fred Hutch cancer metabolism expert Dr. Lucas Sullivan discovered that feeding NRF2-mutated tumors too much of a nutrient they crave makes them vulnerable to slower growth and cell death, a vulnerabil...
072
Reposted by Joan Mancuso
Abigail Johnston @amjohnston.bsky.social · 17/08/2026
Here’s to the women who show up
nohalfmeasures.blog
Gratitude for the People Who Stay
There are people who change your life in dramatic ways and then there are the people who change your life quietly: the ones who never make headlines. The ones who don’t arrive with trumpets or grand speeches. The ones who simply show up, over and over again, until their presence becomes woven into the fabric of your story. Lately, I’ve been thinking about those people. Maybe it’s because cancer has a way of stripping life down to its essentials. Maybe it’s because when you’ve lived long enough in the land of uncertainty, you begin to see more clearly what actually matters.
153
Reposted by Joan Mancuso
KFF Health News @kffhealthnews.org · 17/08/2026
California has distributed 120,000 packs of CalRx generic insulin. It’s @gavinnewsom.bsky.social's experimental initiative to disrupt the pharmaceutical industry, but the drug label has been slow to reach pharmacies and patients.
kffhealthnews.org
Newsom Promotes Affordable Insulin, but California's Generic Label Off to a Slow Start - KFF Health News
California is the first to launch state-branded insulin as Gov. Gavin Newsom tries to disrupt the pharmaceutical industry. But the new CalRx drug label has been slow to reach pharmacies and patients.
077
Reposted by Joan Mancuso
Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 17/08/2026
@dfcibreastonc.bsky.social and the TBCRC are leading the #ETHANstudy, which evaluates endocrine therapies to identify the best treatment for men with ER+/HER2- breast cancer prior to surgery. #MaleBreastCancer For more information call 877-338-7425 or visit: www.dana-farber.org/clinical-tri...
012
Reposted by Joan Mancuso
KFF Health News @kffhealthnews.org · 17/08/2026
One year after Robert F. Kennedy Jr. promised to identify the root cause of autism, he told an impatient President Trump last week that he’s still racing to find answers. kffhealthnews.org/public-health/aut…
kffhealthnews.org
Kennedy's Quiet Hunt for Autism Culprits Stalls as Trump Orders Baseless Changes to Childhood Shots - KFF Health News
The Trump administration is working to implement the president's new order on childhood vaccines, which he publicly faulted for a rise in autism -- even as health secretary Robert F. Kennedy Jr.'s closed-door research has yet to produce evidence linking...
1124
Reposted by Joan Mancuso
JCO Journals @jco-asco.bsky.social · 14/08/2026
Results from the LiBRA study show early ctDNA clearance predicts BRAF therapy success—while rising signals spot resistance weeks before imaging can. Read the full article here: bit.ly/4q0ts9F
011
Reposted by Joan Mancuso
American Association for Cancer Research (AACR) @theaacr.bsky.social · 14/08/2026
Cancer patients are waiting longer to start treatment, Medicare denials may limit access to appropriate cancer drugs, and more from the Week in Cancer News, by the editors of Cancer Today. www.cancertodaymag.org/cancer-talk/...
cancertodaymag.org
The Week in Cancer News: Treatment Delays Grow | Cancer Today
Patients are waiting longer to start treatment than they did a decade ago, and an experimental pancreatic cancer drug is reaching patients ahead of FDA approval.
032
Reposted by Joan Mancuso
Jame Abraham, MD, FACP @jameabraham.bsky.social · 13/08/2026
GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women | JCO Oncology Practice
PURPOSEExcess weight is a key modifiable risk factor for breast cancer. Glucagon-like peptide-1 receptor agonists (GLP-1) promote weight loss and improve metabolic health, but their effect on breast c...
021
Reposted by Joan Mancuso
Dr. Peter Lurie @drpeterlurie.bsky.social · 10/08/2026
In my latest @jama.com piece with @georgetownlaw.bsky.social's @gostin.bsky.social, we argue that recent SCOTUS rulings are dismantling independent public health regulation. By preempting state protections and expanding executive control over agencies, political preference is replacing science.
jamanetwork.com
The Supreme Court and Public Health Regulation
This Viewpoint summarizes the ways in which federal health agencies and state-level safeguards work in parallel to ensure public health and highlights how 3 recent Supreme Court rulings have reduced t...
076
Reposted by Joan Mancuso
Siteman Cancer Center @sitemancenter.bsky.social · 10/08/2026
@washumedicine.bsky.social has been ranked among the top universities in the U.S. and globally in @usnews.com's 2026-2027 Best Global Universities Rankings. usnews.com/education/best-global-universities/united-states/oncology
Upward view of the WashU Medicine sign and shield logo mounted on the exterior of a modern gray metal-paneled building against a clear blue sky.
011
Reposted by Joan Mancuso
OncLive @onclive.bsky.social · 07/08/2026
WATCH: Javier Cortés, MD, PhD, discusses the mechanism of action of evorpacept and its potential role in breast cancer management. #bcsm #oncology See our coverage of recent research with this agent for more insights! www.onclive.com/view/cd47-ex...
011
Reposted by Joan Mancuso
American Society of Clinical Oncology @ascocancer.bsky.social · 07/08/2026
Updated draft guideline recommendations for cardiac, renal, musculoskeletal, & endocrine adverse events in the "Management of Immune-Related Adverse Events in Patients Treated w/ Immune Checkpoint Inhibitor Therapy" are available. Submit feedback by 8/21: bit.ly/4wdr0hr
121
Reposted by Joan Mancuso
APHA @apha.org · 31/07/2026
Yesterday, Georges C. Benjamin, MD, CEO of APHA spoke with NPR on the consequences of devaluing public health and leaders like Dr. Fauci. Read the article, including statements from Benjamin, @ylepidemiologist.bsky.social and Nicole Huberfeld: vist.ly/5d7p6
A white quote on a dark blue background says, "We are less healthy. We've seen it every day, right? This inability to respond effectively to hantavirus, measles, cyclospora." Beneath the quote is the author's name, Georges C. Benjamin, MD, CEO of the American Public Health Association. At the bottom of the graphic is the APHA logo.
0147
Reposted by Joan Mancuso
Union of Concerned Scientists @ucs.org · 07/08/2026
Attacks on science and scientists put us all in danger.
11710
Reposted by Joan Mancuso
JAMA @jama.com · 07/08/2026
#MedNews: #Lyme disease cases are rising, but diagnosis and treatment have changed little over decades. What new approaches are on the horizon, and will they improve clinical care?
jamanetwork.com
Lyme Disease Is Outpacing Medical Advances
This Medical News article discusses the emerging advances in Lyme disease diagnostics, prevention, and therapeutics as well as the practical challenges that continue to limit innovation.
043
Reposted by Joan Mancuso
Union of Concerned Scientists @ucs.org · 07/08/2026
"Despite repeated warnings of the threat that data centers pose to electric system stability, grid reliability is dangling between old fenceposts that separate hyperscale data centers from effective oversight." Read UCS's Lee Shaver's new blog to learn the details:
blog.ucs.org
Data Centers Are Already Stressing the Grid. Regulators Are Playing Catch-up. - Union of Concerned Scientists
Despite repeated warnings of the threat that data centers pose to electric system stability, grid reliability is dangling between old fenceposts that separate hyperscale data centers from effective oversight.
14324
Reposted by Joan Mancuso
Union of Concerned Scientists @ucs.org · 07/08/2026
Many US households are struggling to afford the basics. Gas prices are up 30% and energy bills are rising. Meanwhile, Shell, ExxonMobil, & Chevron have raked in $404 million in profits EVERY DAY over the past 3 months. The need for an energy transition is more apparent than ever. 🧵⬇️
46234
Reposted by Joan Mancuso
ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 04/08/2026
Congratulations to our former champion Dr @mazietsangmd.bsky.social on her induction into @ascocancer.bsky.social prestigious #FASCO designation. #pallonc #supponc
032